e-learning
resources
Amsterdam 2011
Tuesday, 27.09.2011
Lung cell injury and repair
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation
A. Goolaerts, V. Vanneaux, J. Larghero, M. Matthay, C. Clérici (Paris, France)
Source:
Annual Congress 2011 - Lung cell injury and repair
Session:
Lung cell injury and repair
Session type:
Poster Discussion
Number:
4589
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Goolaerts, V. Vanneaux, J. Larghero, M. Matthay, C. Clérici (Paris, France). Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation. Eur Respir J 2011; 38: Suppl. 55, 4589
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Lung function in epidemiological studies from infancy to childhood with focus on urban environment
Occupational and drug-induced ILDs
PG16 Advanced cardiopulmonary exercise testing
Related content which might interest you:
The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
The secretome of lung resident mesenchymal stem cells is anti-fibrotic in vitro and in vivo
Source: International Congress 2018 – Regenerative and anti-fibrotic approaches
Year: 2018
LSC Abstract – Network analysis of induced pluripotent stem cells secretome reveales its anti fibrotic action in rat lung injury model
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016
Using induced pluripotent stem cells to model the human lung alveolar epithelium
Source: International Congress 2018 – Pathophysiology of the human lung alveolus
Year: 2018
The new-defined mesenchymal stromal/stem cell marker has a protective role in the development of acute lung injury.
Source: International Congress 2019 – Involvement of the environment and inflammation in pulmonary remodelling
Year: 2019
Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Source: Eur Respir J 2012; 39: 446-457
Year: 2012
Protective roles of paracrine factors of bone marrow mesenchymal stem cells in bleomycin induced lung epithelial cell injury in vitro and pulmonary fibrosis in vivo
Source: Annual Congress 2010 - Experimental approaches in pulmonary fibrosis
Year: 2010
Progress towards human lung regeneration in end-stage respiratory failure: studying human lung development in vitro using organoid cultures of human embryonic lung stem cells
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018
Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3D organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro
Source: ERS Lung Science Conference 2018
Year: 2018
3D models of human lung development and disease using pluripotent stem cells
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019
Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021
IPF lung resident mesenchymal stem cells differentiate into epithelial cells displaying a disease-specific transcriptome
Source: International Congress 2019 – Intercellular communication in tissue remodelling of chronic lung diseases
Year: 2019
Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015
Immunotherapeutic strategy with mesenchymal stem cells modulating inflammation in an experimental model of COPD.
Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD
Year: 2020
Therapeutic effects of human perivascular stem cells in an emphysema mouse model
Source: International Congress 2017 – From the bench: therapeutic approaches in COPD and emphysema
Year: 2017
Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury
Source: Eur Respir J 2009; 34: 740
Year: 2009
The role of resident lung mesenchymal stromal cells in normal and aberrant lung development
Source: Virtual Congress 2020 – Cellular involvement in lung injury
Year: 2020
Identification of MSC-like cells in human lung parenchyma capable of differentiating into airway epithelial cells
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept